Janus Henderson Venture Fund
Janus Investment Fund · 7 share classes
Fund classification
Classified from what the fund holds · as of 2026 Q2
Janus Henderson Venture Fund is an actively managed U.S. equity fund.
- Asset class
- Equity
- Region
- United States
- Management
- Actively managed
- Fund type
- Open-end fund
Fund profile
As filed in the prospectus · 2026 Q1
Janus Henderson Venture Fund seeks capital appreciation.
The fund invests at least 50% of its net assets in small-capitalization companies defined by the Russell 2000 Growth Index range, using a bottom-up fundamental analysis that evaluates valuation, operating margins, returns on capital, and financially material environmental, social, and governance factors; it may also hold larger companies with strong growth potential and foreign securities. Because the fund's holdings depend on portfolio management's assessment of individual companies rather than an index methodology, performance will diverge from any benchmark. The fund may lend securities up to one-third of assets.
| Share class | Gross | Net |
|---|---|---|
| JAVTX | 0.92% | 0.92% |
| JANVX | 0.79% | — |
| JVTAX | 1.04% | 1.04% |
| JVTCX | 2.04% | 1.96% |
| JVTIX | 0.77% | 0.77% |
| JVTSX | 1.18% | 1.18% |
| JVTNX | 0.67% | 0.67% |
Net is what a holder pays after the adviser's contractual waiver; gross is before it. A waiver can expire.
Portfolio turnover 24.00% · as of 2026 Q1
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 98.28% |
| Cash & short-term | 2.99% |
| Other | 0.01% |
| Derivatives | -0.07% |
The outer band is exposure held short — written against the portfolio rather than part of it, which is why it sits outside the ring and why the two are never netted into one figure.
Derivatives are shown at market value, not notional exposure.
Sector allocation
The same holdings as Allocation above, grouped by market sector instead of asset type · as of 2026 Q2
| Health Care | 26.8% |
| Industrials | 22.7% |
| Information Technology | 13.5% |
| International | 11.1% |
| 10 smaller | 26.0% |
Government, Securitized and Cash are non-corporate buckets; International is foreign holdings we don’t sector-classify, and Other is the residual (held funds, unresolved names).
Latest quarter
What changed since the fund's previous filing
Largest new: Tower Semiconductor Ltd., Cimpress plc, Ascendis Pharma A/S, Gates Industrial Corp. plc, AADX, Nova Ltd., Global-e Online Ltd., HROW
Largest exited: Tower Semiconductor Limited, Ascendis Pharma A/S, CRDO, Gates Industrial Corp PLC, CMPR, Global E Online Ltd, Nova Ltd, Centessa Pharmaceuticals plc
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
| Share class | 1-year | 3-year | 5-year | Vol | Worst fall |
|---|---|---|---|---|---|
| +27.69% | +33.39% | +19.96% | 12.34% | -14.67% | |
| +27.80% | +33.80% | +20.59% | 12.34% | -14.65% | |
| +27.50% | +32.81% | +19.21% | 12.35% | -14.72% | |
| +26.44% | +29.92% | +14.62% | 12.36% | -14.96% | |
| +27.87% | +33.92% | +20.80% | 12.35% | -14.65% | |
| +27.33% | +32.24% | +18.30% | 12.33% | -14.76% | |
| +27.98% | +34.25% | +21.32% | 12.35% | -14.62% |
These classes hold the same portfolio, so the 6.71pp spread over 5 years is the cost difference between them — roughly 1.34pp a year — not a difference in what they own.
May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| GKOS | Glaukos Corp.GKOS | 2.59% | $139.76 | $93.89M | 671.8K |
| LGND | Ligand Pharmaceuticals, Inc.LGND | 2.40% | $316.09 | $87.11M | 275.6K |
| PRM | Perimeter Solutions, Inc.PRM | 2.19% | $35.65 | $79.27M | 2.2M |
| SPXC | SPX Technologies, Inc.SPXC | 2.12% | $245.17 | $76.87M | 313.5K |
| RVMD | Revolution Medicines, Inc.RVMD | 1.99% | $187.28 | $71.99M | 384.4K |
| — | Tower Semiconductor Ltd. | 1.89% | $260.64 | $68.45M | 262.6K |
| CECO | CECO Environmental Corp.CECO | 1.87% | $90.74 | $67.69M | 746.0K |
| LGN | Legence Corp.LGN | 1.73% | $85.23 | $62.72M | 735.9K |
| CASY | Casey's General Stores, Inc.CASY | 1.70% | $794.79 | $61.48M | 77.4K |
| — | Janus Henderson Cash Liquidity Fund LLC | 1.64% | — | $59.36M | — |
Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.
Top 10 positions are 20.13% of net assets, top 25 41.10%, across 142 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free